These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25372732)

  • 41. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
    Boveland SD; Moore PA; Mysore J; Krunkosky TM; Dietrich UM; Jarrett C; Paige Carmichael K
    Vet Ophthalmol; 2010 Mar; 13(2):81-90. PubMed ID: 20447025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation.
    Attia M; Huet E; Gossard C; Menashi S; Tassoni MC; Martelly I
    Am J Sports Med; 2013 Apr; 41(4):908-17. PubMed ID: 23404084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
    Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
    Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positive correlations between circulating adiponectin and MMP2 in preeclampsia pregnant.
    Eleuterio NM; Palei AC; Rangel Machado JS; Tanus-Santos JE; Cavalli RC; Sandrim VC
    Pregnancy Hypertens; 2015 Apr; 5(2):205-8. PubMed ID: 25943646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The anti-angiogenic herbal extracts Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris suppresses adipogenesis in 3T3-L1 adipocytes.
    Hong Y; Kim MY; Yoon M
    Pharm Biol; 2011 Aug; 49(8):775-83. PubMed ID: 21449830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
    Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
    Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
    Tanney DC; Feng L; Pollock AS; Lovett DH
    Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of obesity and tobacco smoke exposure on inflammatory mediators and matrix metalloproteinases in rat model.
    Esquivel AL; Pérez-Ramos J; Cisneros J; Herrera I; Rivera-Rosales R; Montaño M; Ramos C
    Toxicol Mech Methods; 2014 Dec; 24(9):633-43. PubMed ID: 25141943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes.
    He S; Prasanna G; Yorio T
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3737-45. PubMed ID: 17652746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered matrix metalloproteinases and tissue inhibitors of metalloproteinases in embryos from diabetic rats during early organogenesis.
    Higa R; Kurtz M; Capobianco E; Martínez N; White V; Jawerbaum A
    Reprod Toxicol; 2011 Dec; 32(4):449-62. PubMed ID: 21963884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G; Walter I; Helmreich M; Egerbacher M
    Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2.
    Fujimura M; Watanabe M; Shimizu H; Tominaga T
    Acta Neurochir (Wien); 2007 Feb; 149(2):179-83; discussion 183. PubMed ID: 17043747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults.
    Lee YJ; Heo YS; Park HS; Lee SH; Lee SK; Jang YJ
    Obes Surg; 2014 Apr; 24(4):604-10. PubMed ID: 24234777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.
    Olejarz W; Łacheta D; Kubiak-Tomaszewska G
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical training improves visceral adipose tissue health by remodelling extracellular matrix in rats with estrogen absence: a gene expression analysis.
    Duarte FO; Gomes-Gatto CDV; Oishi JC; Lino ADS; Stotzer US; Rodrigues MFC; Gatti da Silva GH; Selistre-de-Araújo HS
    Int J Exp Pathol; 2017 Aug; 98(4):203-213. PubMed ID: 28884865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk.
    Frühbeck G; Catalán V; Rodríguez A; Gómez-Ambrosi J
    Adipocyte; 2018 Jan; 7(1):57-62. PubMed ID: 29205099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix metalloproteinases and coronary artery diseases.
    Ikeda U; Shimada K
    Clin Cardiol; 2003 Feb; 26(2):55-9. PubMed ID: 12625594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.